期刊
NATURE MEDICINE
卷 24, 期 6, 页码 770-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41591-018-0054-2
关键词
-
资金
- NASA Ames Research Center [NNA06CB93G]
- National Institutes of Health (NIH) [P50CA127297, U01CA210240, 5R50CA211462]
- National Cancer Institute [R00CA172697]
- Institutional start-up funds from CUIMC
- Herbert Irving Comprehensive Cancer Center's Cancer Center Support Grant-Inter-Programmatic Pilot Project [5P30CA013696-43]
- [DK080706]
Patients with metastatic cancer experience a severe loss of skeletal muscle mass and function known as cachexia. Cachexia is associated with poor prognosis and accelerated death in patients with cancer, yet its underlying mechanisms remain poorly understood. Here, we identify the metal-ion transporter ZRT-and IRT-like protein 14 (ZIP14) as a critical mediator of cancerinduced cachexia. ZIP14 is upregulated in cachectic muscles of mice and in patients with metastatic cancer and can be induced by TNF-alpha and TGF-beta cytokines. Strikingly, germline ablation or muscle-specific depletion of Zip14 markedly reduces muscle atrophy in metastatic cancer models. We find that ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. Importantly, ZIP14-mediated zinc accumulation in differentiated muscle cells induces myosin heavy chain loss. These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据